Technology news and Jobs
VIRTUALISATION
Magnetize depression away
VIRTUALISATION
Magnetize depression away | Magnetize depression away |
|
| by William Atkins | |
| Monday, 03 November 2008 | |
|
Page 1 of 2
The U.S. Food and Drug Administrtion (FDA) approves transcranial magnetic stimulation (TMS) as a treatment for depression for those unable to respond to traditional antidepressant drug therapies.Featured Whitepaper
5 Best Practices for Smartphone Support
Transcranial magnetic stimulation (which is abbreviated TMS) uses an electromagnetic coil that is placed over the head of the patient. See a picture of the device at: TMS Device. The coil then delivers concentrated magnetic pulses—the strength of magnetic pulses used for magnetic resonance imaging (MRI) scans—to the brain in order to induce a weak electric current to brain tissue. The device works when the coil’s magnetic field excites nerve cells in the brain that regulate mood. According to the New Scientist article “Brain tickler,” Andrew Thomas, a spokesperson for United Kingdom-based The Magstim Company, stated, “It is a very significant step forward, as everyone looks to the U.S. as the leader.” [New Scientist, October 25-31, 2008, page 7] The 40-minute procedure is usually administered daily for four to six weeks, and will be available through outpatient care. The approval of the new depression treatment, which was announced by FDA on October 8, 2008, is based on studies with 164 patients who had major depression but were unable to eliminate their symptoms with traditional drug therapies. The results of the experiment is found on page two. |
| < Next story in category | Previous story in the category > |
|---|









